KRT19 and neoplasm: To ensure that different levels of tumor cells or inflammatory cells in the primary tumors and their matched metastasis did not bias our data, we quantified the mRNA levels of KRT19 and EPCAM (as a measure for epithelial content) and PTPRC (the gene for the common leukocyte antigen CD45, as a measure for the presence of lymphocytes).